Organization: Health Canada
Year: 2022
Month: August
Request Number: A-2021-001497
Request Summary: Adverse Drug Reactions (ADRs) for MESALAZINE. Report numbers: E2B_04484269, E2B_04494416, E2B_04460249, E2B_04432576, E2B_04363203, E2B_04462295, E2B_04436295, E2B_04404907, E2B_04432594, E2B_04449163, E2B_04414170, E2B_04417110, E2B_04413887, E2B_04402351, E2B_04470225, E2B_04441940, E2B_04463453. ADRs for VYVANSE. Report numbers: E2B_04492112, 000958293.
Disposition: Disclosed in part
Number of pages: 510